ARTICLE SUMMARY:
NaviGate Cardiac Structures has come up with a unique solution to the challenges of transcatheter tricuspid and mitral valve replacement. The firm’s novel, truncated cone-shaped device design enables it to produce a large diameter stented valve with a lower height profile.
Southern California-based start-up NaviGate Cardiac Structures Inc. (NCSI) has a lofty goal: to make transcatheter tricuspid and mitral heart valve replacement a clinical reality.
